Don't just stand there, do something: strategies for the prevention of early death in acute promyelocytic leukemia: a commentary

Blood Cells Mol Dis. 2011 Feb 15;46(2):173-4. doi: 10.1016/j.bcmd.2010.12.001. Epub 2011 Jan 11.
No abstract available

MeSH terms

  • Anthracyclines / administration & dosage
  • Anthracyclines / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Arsenic Trioxide
  • Arsenicals / administration & dosage
  • Arsenicals / therapeutic use
  • Disseminated Intravascular Coagulation / prevention & control
  • Hemorrhage / prevention & control
  • Humans
  • Leukemia, Promyelocytic, Acute / diagnosis*
  • Leukemia, Promyelocytic, Acute / drug therapy
  • Leukemia, Promyelocytic, Acute / mortality*
  • Leukemia, Promyelocytic, Acute / physiopathology
  • Oxides / administration & dosage
  • Oxides / therapeutic use
  • Remission Induction
  • Secondary Prevention
  • Survival Rate
  • Time Factors
  • Treatment Failure
  • Tretinoin / administration & dosage
  • Tretinoin / therapeutic use

Substances

  • Anthracyclines
  • Arsenicals
  • Oxides
  • Tretinoin
  • Arsenic Trioxide